DETERMINANTS OF CHRONIC RENAL ALLOGRAFT REJECTION IN CYCLOSPORINE-TREATED RECIPIENTS
- 15 November 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 62 (9) , 1235-1241
- https://doi.org/10.1097/00007890-199611150-00009
Abstract
We analyzed the development of chronic rejection in 511 kidney-only renal transplants in 507 patients between July 1987 and November 1994. A database was established for recipients ≥18 years old who received cyclosporine-based immunosuppression and demonstrated graft survival for a minimum of 12 months. The 347 recipients of cadaver transplants (67.9%) and 164 recipients of live donor transplants (32.1%) were followed for 12 to 102 months (mean 51 months). Chronic rejection was diagnosed in 124 transplants(24%), with a mean time to diagnosis of 23±18 months (range 3-92). Risk factors were identified in a multivariate analysis using the Cox model. The impact of the timing and severity of rejection episodes was analyzed in a univariate model. The presence of chronic rejection resulted in decreased(P=0.0001) 5-year graft survival for both cadaver graft(83.7% vs. 58.2%) and live donor graft (93.2% vs. 53.1%) recipients. Significant variables for the development of chronic rejection included an acute rejection episode (P=0.0001), a black recipient(P=0.0006), donor age ≥50 years(P=0.006), and a serum creatinine level >2.0 mg/dl by 6 months after transplantation. Severity of rejection measured by peak serum creatinine or posttreatment return to baseline was not related to chronic rejection. However, acute rejection episodes lasting for more that 5 days(P=0.03) or occurring after 6 months(P=0.001) did influence time to chronic rejection. In addition, mismatching for donor-recipient race was a significant(P=0.008) risk factor for recipients of cadaver grafts. We conclude that acute rejection is the most significant risk factor for chronic rejection, and the long-term fate of grafts may be determined as early as the first 6 months. Racial matching of donor-recipient pairs may be useful to minimize chronic rejection risk. Future advances that diminish the incidence and severity of acute rejection may have the greatest impact on long-term survival.Keywords
This publication has 23 references indexed in Scilit:
- Chronic renal allograft rejection: Immunologic and nonimmunologic risk factorsKidney International, 1996
- Chronic transplant rejectionKidney International, 1994
- RISK FACTORS PREDICTING CHRONIC REJECTION OF RENAL ALLOGRAFTSTransplantation, 1994
- International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathologyKidney International, 1993
- LRISK FACTORS FOR CHRONIC REJECTION IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1993
- Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplantsKidney International, 1993
- Histopathological findings in well-functioning, long-term renal allograftsKidney International, 1992
- Effects of dietary protein in patients with chronic renal transplant rejectionKidney International, 1992
- Causes of Renal Allograft LossAnnals of Surgery, 1991
- Histopathologic findings associated with a chronic, progressive decline in renal allograft functionKidney International, 1991